For example, Takahiro Maeda et al. [25] reported that targeting MUC1-C associated with PD-L1 suppression could increase tumor-infiltrating CD8+ T cells quantity and tumor cell killing ability, which inversely correlates to CD8, CD69, and GZMB markers. This evidence concerns the gene CD69 and neoplasm.